Meng Chao Hepatobiliary Hospital of Fujian Medical University
19
6
9
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.5% vs industry average
5%
1 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Prevention of AIDS With Opportunistic Infection Paradoxical IRIS
Role: collaborator
AI-Assisted Staging and Treatment Decision-Making for Hepatocellular Carcinoma
Role: collaborator
Real-world Cohort Study of Antiretroviral Therapy in HIV Patients With Opportunistic Infections
Role: collaborator
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
Role: collaborator
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
Role: collaborator
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
Role: collaborator
A Digital Tongue Diagnosis Model for High- and Low-risk Esophagogastroduodenal Varices in Cirrhosis
Role: collaborator
A Trial of Cadonilimab Plus Regorafenib in Patients With Hepatocellular Carcinoma Who Failed Camrelizumab Combined With Apatinib
Role: lead
A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma
Role: lead
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree
Role: collaborator
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Role: collaborator
Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)
Role: collaborator
HCC Staging Modified by Tumor Micronecrosis
Role: collaborator
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
Role: collaborator
Dolutegravir Plus Lamivudine Simplified Therapy
Role: collaborator
Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases
Role: collaborator
A Multicenter Prospective Study of Application of Platelet Mapping in Acute-on-chronic-liver Failure in China
Role: collaborator
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
Role: collaborator
All 19 trials loaded